Chlorpromazine, Quant




Test Mnemonic

CLORPR

CPT Codes

  • 80342 - QTY (1)
  • G0480 - QTY (1)

Aliases

  • Largactil
  • Ormazine
  • Thorazine

Performing Laboratory

ARUP

FDA Category

Laboratory Developed Test


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
2 mLSerumNo additive (Red) FrozenPredose (trough) draw - At steady state concentration. Do NOT draw separator tubes. Remove serum from cells ASAP or within 2 hours of collection and transfer into a standard aliquot tube.

Alternate Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
2 mLPlasmaEDTA (Lavender) FrozenPredose (trough) draw - At steady state concentration. Do NOT draw separator tubes. Remove plasma from cells ASAP or within 2 hours of collection and transfer into a standard aliquot tube.
2 mLPlasmaSodium or Lithium heparin (Green) FrozenPredose (trough) draw - At steady state concentration. Do NOT draw separator tubes. Remove plasma from cells ASAP or within 2 hours of collection and transfer into a standard aliquot tube.
2 mLPlasmaPotassium oxalate/sodium fluoride (Gray) FrozenPredose (trough) draw - At steady state concentration. Do NOT draw separator tubes. Remove plasma from cells ASAP or within 2 hours of collection and transfer into a standard aliquot tube.

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
0.5 mL     

Stability

Environmental Condition Description
AmbientAfter separation from cells: Unacceptable
FrozenAfter separation from cells: 14 days
RefrigeratedAfter separation from cells: 14 days

Days Performed

Mon

Turnaround Time

9 - 10 days

Methodology

Name Description
Quantitative Liquid Chromatography - Tandem Mass Spectrometry 

Reference Range

Chlorpromazine
Sex Age From Age To Type Range Range Unit
       Normal30 - 300ng/mL
       Critical> or = 600ng/mL

Special Info

Draw trough specimen before the next dose at steady state concentration. Whole blood, gel separator tubes, hemolyzed samples, citrate (light blue) tube, and tubes with SPS or ACD (yellow) solution will be rejected.

Clinical Info

Chlorpromazine is a neuroleptic drug indicated for the treatment of schizophrenia, psychotic disorders and intractable hiccup. Chlorpromazine should not be used in patients who have epilepsy, Parkinson’s disease, hypoparathyroidism, myasthenia gravis, and prostatic hypertrophy. Adverse effects may include drowsiness, hypotension, agranulocytosis, cardiac abnormalities, seizures and rare life-threatening effects, such as phenothiazine sudden death syndrome, and neuroleptic malignant syndrome.